{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:49:35Z","timestamp":1791420575849,"version":"4.3.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Homeobox (HOX) gene family is capable of binding to specific deoxyribonucleic acid (DNA) sequences, thereby modulating gene expression through activation or repression, which subsequently influences cellular behaviors including proliferation, adhesion, differentiation, and metastasis. Nevertheless, the role of Homeobox D10 (HOXD10) in the prognosis and progression of hepatocellular carcinoma (HCC) remains to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression of HOXD10 in HCC was subsequently validated through Western blot and immunohistochemistry analysis. The functional role of HOXD10 in HCC was evaluated using a combination of high- and low-expression experiments, incorporating both in vitro and in vivo methodologies. Furthermore, The Cancer Genome Atlas (TCGA) database was employed to investigate the functional networks related to HOXD10. The research specifically investigated the relationship between HOXD10 expression and cancer stem cells (CSCs), emphasizing the role of N6-methyladenosine (m6A) methylation and the PI3K\/AKT\/mTOR signaling pathway in hepatocellular carcinoma (HCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The marked upregulation of HOXD10 expression in HCC suggests its potential impact on adverse prognostic outcomes. Furthermore, HOXD10 expression exhibited a significant association with the T stage, vascular invasion, and histological grade of HCC. Elevated HOXD10 expression was found to significantly enhance HCC cell proliferation, invasion, and migration. Notably, there was a significant correlation between HOXD10 expression and the activation of m6A methylation, as well as the PI3K\/AKT\/mTOR signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of this study corroborate the hypothesis that HOXD10 serves as a novel biomarker for tumor progression in HCC. Furthermore, HOXD10 has the capacity to activate the PI3K\/AKT\/mTOR signaling pathway through the regulation of m6A RNA methylation levels, thereby facilitating the self-renewal of hepatic cancer stem cells (HCSCs).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08632-x","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:24:18Z","timestamp":1783931058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HOXD10 promotes hepatocellular carcinoma progression by enhancing m6A methylation and activating the PI3K\/AKT\/mTOR pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Chengdong","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-8078","authenticated-orcid":false,"given":"Dening","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"3","key":"8632_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl S1","key":"8632_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl S1):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288.","journal-title":"Hepatology"},{"issue":"1","key":"8632_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"8632_CR4","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","volume":"21","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Wong G, Anstee QM, Henry L. The global burden of liver disease. Clin Gastroenterol Hepatol. 2023;21(8):1978\u201391. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.015.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"8632_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00432-020-03366-9","volume":"147","author":"YQ Jiang","year":"2021","unstructured":"Jiang YQ, Cao SE, Cao S, Chen JN, Wang GY, Shi WQ, et al. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning. J Cancer Res Clin Oncol. 2021;147(3):821\u201333. https:\/\/doi.org\/10.1007\/s00432-020-03366-9.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"8632_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/SLA.0b013e31821ad884","volume":"254","author":"KC Lim","year":"2011","unstructured":"Lim KC, Chow PK-H, Allen JC, Chia GS, Lim M, Cheow PC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254(1):108\u201313. https:\/\/doi.org\/10.1097\/SLA.0b013e31821ad884.","journal-title":"Ann Surg"},{"issue":"2","key":"8632_CR7","doi-asserted-by":"publisher","first-page":"9420025","DOI":"10.26599\/FMH.2024.9420025","volume":"1","author":"J Wang","year":"2024","unstructured":"Wang J, Liao Z. Research progress of microrobots in tumor drug delivery. Food Med Homol. 2024;1(2):9420025. https:\/\/doi.org\/10.26599\/FMH.2024.9420025.","journal-title":"Food Med Homol"},{"issue":"3","key":"8632_CR8","doi-asserted-by":"publisher","first-page":"9420120","DOI":"10.26599\/FMH.2025.9420120","volume":"2","author":"M Li","year":"2025","unstructured":"Li M, Zhang Q, Li J, Zengin G. Food and medicine homology in cancer treatment: traditional thoughts collide with scientific evidence. Food Med Homol. 2025;2(3):9420120. https:\/\/doi.org\/10.26599\/FMH.2025.9420120.","journal-title":"Food Med Homol"},{"issue":"1","key":"8632_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med4.51","volume":"2","author":"R Sharma","year":"2024","unstructured":"Sharma R, Malviya R. Modifying the electrical, optical, and magnetic properties of cancer cells: a comprehensive approach for cancer management. Med Adv. 2024;2(1):3\u201319. https:\/\/doi.org\/10.1002\/med4.51.","journal-title":"Med Adv"},{"key":"8632_CR10","doi-asserted-by":"publisher","first-page":"153303382311636","DOI":"10.1177\/15330338231163677","volume":"22","author":"AG Quiroz Reyes","year":"2023","unstructured":"Quiroz Reyes AG, Lozano Sepulveda SA, Martinez-Acu\u00f1a N, Islas JF, Gonzalez PD, Heredia Torres TG, et al. Cancer stem cell and hepatic stellate cells in hepatocellular carcinoma. Technol Cancer Res Treat. 2023;22:15330338231163677. https:\/\/doi.org\/10.1177\/15330338231163677.","journal-title":"Technol Cancer Res Treat"},{"key":"8632_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.semcancer.2019.09.007","volume":"60","author":"TB Steinbichler","year":"2020","unstructured":"Steinbichler TB, Savic D, Dud\u00e1s J, Kvitsaridze I, Skvortsov S, Riechelmann H, et al. Cancer stem cells and their unique role in metastatic spread. Semin Cancer Biol. 2020;60:148\u201356. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.007.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8632_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","volume":"20","author":"C Yao","year":"2023","unstructured":"Yao C, Wu S, Kong J, Sun Y, Bai Y, Zhu R, et al. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biol Med. 2023;20(1):25\u201343. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0449.","journal-title":"Cancer Biol Med"},{"key":"8632_CR13","doi-asserted-by":"publisher","first-page":"105507","DOI":"10.1016\/j.phrs.2021.105507","volume":"166","author":"N Zheng","year":"2021","unstructured":"Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res. 2021;166:105507. https:\/\/doi.org\/10.1016\/j.phrs.2021.105507.","journal-title":"Pharmacol Res"},{"issue":"10","key":"8632_CR14","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/cas.13740","volume":"109","author":"X Zhao","year":"2018","unstructured":"Zhao X, Sun B, Liu T, Shao B, Sun R, Zhu D, et al. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma. Cancer Sci. 2018;109(10):3197\u2013208. https:\/\/doi.org\/10.1111\/cas.13740.","journal-title":"Cancer Sci"},{"key":"8632_CR15","doi-asserted-by":"publisher","first-page":"696802","DOI":"10.3389\/fphar.2021.696802","volume":"12","author":"X Ba","year":"2021","unstructured":"Ba X, Huang Y, Shen P, Huang Y, Wang H, Han L, et al. WTD attenuating rheumatoid arthritis via suppressing angiogenesis and modulating the PI3K\/AKT\/mTOR\/HIF-1\u03b1 pathway. Front Pharmacol. 2021;12:696802. https:\/\/doi.org\/10.3389\/fphar.2021.696802.","journal-title":"Front Pharmacol"},{"issue":"11","key":"8632_CR16","doi-asserted-by":"publisher","first-page":"e1009876","DOI":"10.1371\/journal.pgen.1009876","volume":"17","author":"RR Madsen","year":"2021","unstructured":"Madsen RR, Erickson EC, Rueda OM, Robin X, Caldas C, Toker A, et al. Positive correlation between transcriptomic stemness and PI3K\/AKT\/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype. PLoS Genet. 2021;17(11):e1009876. https:\/\/doi.org\/10.1371\/journal.pgen.1009876.","journal-title":"PLoS Genet"},{"issue":"3","key":"8632_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ygyno.2016.03.004","volume":"141","author":"KR Miller","year":"2016","unstructured":"Miller KR, Patel JN, Ganapathi MK, Tait DL, Ganapathi RN. Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer. Gynecol Oncol. 2016;141(3):608\u201315. https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.004.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"8632_CR18","doi-asserted-by":"publisher","first-page":"e1606","DOI":"10.1002\/wsbm.1606","volume":"15","author":"J de Faria Poloni","year":"2023","unstructured":"de Faria Poloni J, Feltes BC. Potential role of exitron-containing homeobox genes in cancer. WIREs Mech Dis. 2023;15(3):e1606. https:\/\/doi.org\/10.1002\/wsbm.1606.","journal-title":"WIREs Mech Dis"},{"issue":"1","key":"8632_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-021-09657-2","volume":"38","author":"US Shenoy","year":"2022","unstructured":"Shenoy US, Adiga D, Kabekkodu SP, Hunter KD, Radhakrishnan R. Molecular implications of HOX genes targeting multiple signaling pathways in cancer. Cell Biol Toxicol. 2022;38(1):1\u201330. https:\/\/doi.org\/10.1007\/s10565-021-09657-2.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"8632_CR20","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1002\/jcp.27975","volume":"234","author":"S Bhatlekar","year":"2019","unstructured":"Bhatlekar S, Ertel A, Gonye GE, Fields JZ, Boman BM. Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer. J Cell Physiol. 2019;234(8):13042\u201356. https:\/\/doi.org\/10.1002\/jcp.27975.","journal-title":"J Cell Physiol"},{"key":"8632_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.semcancer.2017.08.004","volume":"51","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol. 2018;51:149\u201359. https:\/\/doi.org\/10.1016\/j.semcancer.2017.08.004.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8632_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-021-01362-2","volume":"20","author":"S Shen","year":"2021","unstructured":"Shen S, Zhang R, Jiang Y, Li Y, Lin L, Liu Z, et al. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types. Mol Cancer. 2021;20(1):67. https:\/\/doi.org\/10.1186\/s12943-021-01362-2.","journal-title":"Mol Cancer"},{"key":"8632_CR23","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613. https:\/\/doi.org\/10.1016\/j.biopha.2019.108613.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8632_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","volume":"40","author":"C Song","year":"2021","unstructured":"Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis. J Exp Clin Cancer Res. 2021;40(1):62. https:\/\/doi.org\/10.1186\/s13046-021-01859-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"8632_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L, Han Y, He Q. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J Intgr Biol. 2012;16(5):284\u201387. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics: J Intgr Biol"},{"issue":"2","key":"8632_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7","volume":"66","author":"FX Sun","year":"1996","unstructured":"Sun FX, Tang ZY, Liu KD, Ye SL, Xue Q, Gao DM, et al. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer. 1996;66(2):239\u201343. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19960410)66:2%253C239::AID-IJC17%253E3.0.CO;2-7.","journal-title":"Int J Cancer"},{"issue":"2","key":"8632_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338\u201354.e15. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"key":"8632_CR28","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkz1001","volume":"48","author":"O Fornes","year":"2019","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2019;48:D87\u20138792. https:\/\/doi.org\/10.1093\/nar\/gkz1001.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"8632_CR29","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1007\/s12010-023-04443-8","volume":"195","author":"C Yi","year":"2023","unstructured":"Yi C, Wei W, Wan M, Chen Y, Zhang B, Wu W. Expression patterns of HOX gene family defines tumor microenvironment and immunotherapy in hepatocellular carcinoma. Appl Biochem Biotechnol. 2023;195(8):5072\u201393. https:\/\/doi.org\/10.1007\/s12010-023-04443-8.","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"8632_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12957-015-0673-8","volume":"13","author":"YY Wang","year":"2015","unstructured":"Wang YY, Li L, Ye ZY, Zhao ZS, Yan ZL. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. World J Surg Oncol. 2015;13(1):259. https:\/\/doi.org\/10.1186\/s12957-015-0673-8.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"8632_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.7150\/jca.18169","volume":"8","author":"Z Lin","year":"2017","unstructured":"Lin Z, Luo M, Chen X, He X, Qian Y, Lai S, et al. Combined detection of plasma ZIC1, HOXD10 and RUNX3 methylation is a promising strategy for early detection of gastric cancer and precancerous lesions. J Cancer. 2017;8(6):1038\u201344. https:\/\/doi.org\/10.7150\/jca.18169.","journal-title":"J Cancer"},{"issue":"11","key":"8632_CR32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/kjm2.12422","volume":"37","author":"FJ Lai","year":"2021","unstructured":"Lai FJ, Yu H, Xie YY, He N. Circ_0000317\/microRNA-520g\/HOXD10 axis affects the biological characteristics of colorectal cancer. Kaohsiung J Med Sci. 2021;37(11):951\u201363. https:\/\/doi.org\/10.1002\/kjm2.12422.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"8632_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-018-0316-0","volume":"17","author":"YH Yuan","year":"2019","unstructured":"Yuan YH, Wang HY, Lai Y, Zhong W, Liang WL, Yan FD, et al. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC\/AKT\/MAPK signaling pathway. Cell Commun Signal. 2019;17(1):9. https:\/\/doi.org\/10.1186\/s12964-018-0316-0.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"8632_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.7150\/jca.90970","volume":"15","author":"CY Hsu","year":"2024","unstructured":"Hsu CY, Tsai CC, Lin HY, Chen HL, Ou YC, Chiang PH, et al. Gene expression profile analysis of the molecular mechanism of HOXD10 regulation of epithelial ovarian cancer cells. J Cancer. 2024;15(5):1213\u201324. https:\/\/doi.org\/10.7150\/jca.90970.","journal-title":"J Cancer"},{"key":"8632_CR35","doi-asserted-by":"publisher","first-page":"771528","DOI":"10.3389\/fonc.2021.771528","volume":"11","author":"W Pan","year":"2021","unstructured":"Pan W, Wang K, Li J, Li H, Cai Y, Zhang M, et al. Restoring HOXD10 exhibits therapeutic potential for ameliorating malignant progression and 5-fluorouracil resistance in colorectal cancer. Front Oncol. 2021;11:771528. https:\/\/doi.org\/10.3389\/fonc.2021.771528.","journal-title":"Front Oncol"},{"issue":"1","key":"8632_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s11658-021-00268-7","volume":"26","author":"X Sun","year":"2021","unstructured":"Sun X, Hou L, Qiu C, Kong B. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. Cell Mol Biol Lett. 2021;26(1):20. https:\/\/doi.org\/10.1186\/s11658-021-00268-7.","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"8632_CR37","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/1878-0261.13059","volume":"15","author":"R Bogeska","year":"2021","unstructured":"Bogeska R. HOX gene regulation in glioma stem cells, mediators of resistance in breast cancer, and paradoxical therapeutic interventions. Mol Oncol. 2021;15(8):1973\u201374. https:\/\/doi.org\/10.1002\/1878-0261.13059.","journal-title":"Mol Oncol"},{"issue":"1","key":"8632_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-60","volume":"10","author":"M Tabuse","year":"2011","unstructured":"Tabuse M, Ohta S, Ohashi Y, Fukaya R, Misawa A, Yoshida K, et al. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Mol Cancer. 2011;10(1):1\u201314. https:\/\/doi.org\/10.1186\/1476-4598-10-60.","journal-title":"Mol Cancer"},{"issue":"5","key":"8632_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24054522","volume":"24","author":"CL Alves","year":"2023","unstructured":"Alves CL, Ditzel HJ. Drugging the PI3K\/AKT\/mTOR pathway in ER+ breast cancer. Int J Mol Sci. 2023;24(5):24. https:\/\/doi.org\/10.3390\/ijms24054522.","journal-title":"Int J Mol Sci"},{"key":"8632_CR40","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.18632\/aging.204559","volume":"15","author":"L Yang","year":"2023","unstructured":"Yang L, Dong Z, Li S, Chen T. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K\/Akt\/mTOR pathway, thus accelerating tumor progression. Aging (Albany NY). 2023;15:2920\u201336. https:\/\/doi.org\/10.18632\/aging.204559.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"8632_CR41","doi-asserted-by":"publisher","first-page":"e18020","DOI":"10.1111\/jcmm.18020","volume":"28","author":"T Wang","year":"2024","unstructured":"Wang T, Chen S, Wang Z, Li S, Fei X, Wang T, et al. KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K\/AKT\/mTOR pathway. J Cell Mol Med. 2024;28(1):e18020. https:\/\/doi.org\/10.1111\/jcmm.18020.","journal-title":"J Cell Mol Med"},{"key":"8632_CR42","doi-asserted-by":"publisher","first-page":"216609","DOI":"10.1016\/j.canlet.2024.216609","volume":"584","author":"X Mei","year":"2024","unstructured":"Mei X, Xiong J, Liu J, Huang A, Zhu D, Huang Y, et al. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4\/PI3K\/AKT axis and VEGF-C secretion. Cancer Lett. 2024;584:216609. https:\/\/doi.org\/10.1016\/j.canlet.2024.216609.","journal-title":"Cancer Lett"},{"key":"8632_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8632_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12672-023-00786-0","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Guo Q, Shi Q, Rao Y, Dong Y, Chen F, et al. M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN\/AKT\/mTOR signaling pathway. Discover Oncol. 2023;14(1):175. https:\/\/doi.org\/10.1007\/s12672-023-00786-0.","journal-title":"Discover Oncol"},{"issue":"2","key":"8632_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ijo.2023.5598","volume":"64","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Huang Q, Wu C, Xu Y, Guo Y, Yuan X, et al. m6A-modified HOXC10 promotes HNSCC progression via co-activation of ADAM17\/EGFR and Wnt\/\u03b2-catenin signaling. Int J Oncol. 2023;64(2):10. https:\/\/doi.org\/10.3892\/ijo.2023.5598.","journal-title":"Int J Oncol"},{"issue":"23","key":"8632_CR46","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1021\/jacs.1c03852","volume":"143","author":"J Liu","year":"2021","unstructured":"Liu J, Chen H, Kaniskan H\u00dc, Xie L, Chen X, Jin J, et al. TF-PROTACs enable targeted degradation of transcription factors. J Am Chem Soc. 2021;143(23):8902\u201310. https:\/\/doi.org\/10.1021\/jacs.1c03852.","journal-title":"J Am Chem Soc"},{"issue":"11","key":"8632_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17111871","volume":"17","author":"H Jung","year":"2025","unstructured":"Jung H, Lee Y. Targeting the undruggable: recent progress in PROTAC-Induced transcription factor degradation. Cancers (Basel). 2025;17(11):17. https:\/\/doi.org\/10.3390\/cancers17111871.","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08632-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:52:34Z","timestamp":1791417154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08632-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8632"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08632-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics of clinical specimens was reviewed and approved by Experimental Ethics Committee of Zhejiang Cancer Hospital (zjzlyyIRB-2021-379); the animal study was reviewed and approved by Experimental Animal Ethics Committee of Zhejiang Cancer Hospital (zjzlsd2022-02-080).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1261"}}